Skip to main contentRemandedUnresolvableUnresolvableUnresolvableUnresolvable
Astrazeneca AB v. Mylan Laboratories, Inc.
Federal CircuitJune 10, 2008No. Nos. 2007-1476, 2007-1477, 2007-1478Cited 6 times
Defendant WinMylan Laboratories, Inc.
Case Details
- Judge(s)
- Bryson, Gajarsa, Lourie
- Status
- Published
- Procedural Posture
- appeal
- Circuit
- Federal Circuit
Related Laws
No specific laws identified for this ruling.
Outcome
The appellate court affirmed the district court's bench trial finding that Mylan's generic omeprazole products did not infringe Astrazeneca's patents because Astrazeneca failed to prove the presence of an alkaline reacting compound (ARC) in the accused products.
Similar Rulings
Blue Cross & Blue Shield v. Mylan Laboratories, Inc.
D.C. CircuitJan 2011
Astrazeneca AB v. Mylan Laboratories, Inc.
Federal CircuitFeb 2008
Astrazeneca AB v. Mylan Laboratories, Inc.
Federal CircuitJan 2008
Nvlsp v. United States
Federal CircuitMar 2026
In Re VOLKSWAGEN GROUP OF AMERICA, INC.
Federal CircuitMar 2026
Facing something similar at work?
Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.
This ruling information is sourced from public court records via CourtListener.com. It is provided for informational and educational purposes only and does not constitute legal advice.